Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

AIMS: Metal absorbable scaffolds constitute a conceptually attractive alternative to polymeric scaffolds. Promising 6-month outcomes of a second-generation drug-eluting absorbable metal scaffold (DREAMS 2G), consisting of an absorbable magnesium scaffold backbone, have been reported. We assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Haude, Michael, Ince, Hüseyin, Abizaid, Alexandre, Toelg, Ralph, Lemos, Pedro Alves, von Birgelen, Clemens, Christiansen, Evald Høj, Wijns, William, Neumann, Franz-Josef, Kaiser, Christoph, Eeckhout, Eric, Lim, Soo Teik, Escaned, Javier, Onuma, Yoshinobu, Garcia-Garcia, Hector M., Waksman, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Fasttrack Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037291/
https://www.ncbi.nlm.nih.gov/pubmed/27190094
http://dx.doi.org/10.1093/eurheartj/ehw196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037291/
https://www.ncbi.nlm.nih.gov/pubmed/27190094
http://dx.doi.org/10.1093/eurheartj/ehw196

Ejemplares similares